Cargando…
Prognostic importance of the fusion partners and measurable residual disease in patients with acute myeloid leukemia who harbor 11q23/KMT2A alterations
Autor principal: | Mrózek, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644025/ https://www.ncbi.nlm.nih.gov/pubmed/37969120 http://dx.doi.org/10.21037/tp-23-360 |
Ejemplares similares
-
Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/
KMT2A
rearrangements
por: Yuen, Ka‐Yuk, et al.
Publicado: (2022) -
Rare Gene Rearrangement t(11;22)(q23;q13)/KMT2A-EP300 in Therapy-related Acute Myeloid Leukemia: A Case Report
por: Kim, Seo Wan, et al.
Publicado: (2022) -
MLL-SEPT5 Fusion Transcript in Two de novo Acute Myeloid Leukemia Patients With t(11;22)(q23;q11)
por: Wang, Nana, et al.
Publicado: (2016) -
Mixed lineage leukemia-septin 5 fusion transcript in de novo adult acute myeloid leukemia with t(11;22)(q23;q11.2): A case report
por: GAO, WEN, et al.
Publicado: (2014) -
Expanding diagnostic criteria: Multiorgan T-Cell/myeloid mixed phenotype acute leukemia with t(v;11q23) KMT2A-rearrangement successfully treated by allogeneic stem cell transplant
por: Syed, Suhayb, et al.
Publicado: (2022)